| Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? C Pellegrini, L Antonioli, R Colucci, C Blandizzi, M Fornai Acta neuropathologica 136, 345-361, 2018 | 219 | 2018 |
| Canonical and non-canonical activation of NLRP3 inflammasome at the crossroad between immune tolerance and intestinal inflammation C Pellegrini, L Antonioli, G Lopez-Castejon, C Blandizzi, M Fornai Frontiers in immunology 8, 237490, 2017 | 204 | 2017 |
| Development of an acrylate derivative targeting the NLRP3 inflammasome for the treatment of inflammatory bowel disease M Cocco, C Pellegrini, H Martínez-Banaclocha, M Giorgis, E Marini, ... Journal of Medicinal Chemistry 60 (9), 3656-3671, 2017 | 146 | 2017 |
| USP7 and USP47 deubiquitinases regulate NLRP3 inflammasome activation P Palazón‐Riquelme, JD Worboys, J Green, A Valera, F Martín‐Sánchez, ... EMBO reports 19 (10), e44766, 2018 | 139 | 2018 |
| Histochemical detection of collagen fibers by sirius red/fast green is more sensitive than van gieson or sirius red alone in normal and inflamed rat colon C Segnani, C Ippolito, L Antonioli, C Pellegrini, C Blandizzi, A Dolfi, ... PloS one 10 (12), e0144630, 2015 | 133 | 2015 |
| Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation G Gerna, D Lilleri, A Chiesa, P Zelini, M Furione, G Comolli, C Pellegrini, ... American Journal of Transplantation 11 (11), 2463-2471, 2011 | 114 | 2011 |
| Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? C Pellegrini, L Antonioli, V Calderone, R Colucci, M Fornai, C Blandizzi Progress in neurobiology 191, 101806, 2020 | 112 | 2020 |
| NKG2A and COVID-19: another brick in the wall L Antonioli, M Fornai, C Pellegrini, C Blandizzi Cellular & molecular immunology 17 (6), 672-674, 2020 | 102 | 2020 |
| Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration C Pellegrini, M Fornai, R Colucci, E Tirotta, F Blandini, G Levandis, ... Journal of neuroinflammation 13, 1-13, 2016 | 86 | 2016 |
| Phytochemicals as novel therapeutic strategies for NLRP3 inflammasome-related neurological, metabolic, and inflammatory diseases C Pellegrini, M Fornai, L Antonioli, C Blandizzi, V Calderone International journal of molecular sciences 20 (12), 2876, 2019 | 83 | 2019 |
| The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications L Antonioli, R Colucci, C Pellegrini, G Giustarini, M Tuccori, C Blandizzi, ... Pharmacology & therapeutics 139 (2), 157-188, 2013 | 73 | 2013 |
| Gastric motor dysfunctions in Parkinson's disease: current pre-clinical evidence C Pellegrini, L Antonioli, R Colucci, V Ballabeni, E Barocelli, N Bernardini, ... Parkinsonism & related disorders 21 (12), 1407-1414, 2015 | 65 | 2015 |
| Constipation, deficit in colon contractions and alpha-synuclein inclusions within the colon precede motor abnormalities and neurodegeneration in the central nervous system in a … L Rota, C Pellegrini, L Benvenuti, L Antonioli, M Fornai, C Blandizzi, ... Translational neurodegeneration 8, 1-15, 2019 | 63 | 2019 |
| Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review D Gentile, M Fornai, C Pellegrini, R Colucci, C Blandizzi, L Antonioli Nutrition research reviews 31 (2), 239-247, 2018 | 63 | 2018 |
| The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity D Gentile, M Fornai, R Colucci, C Pellegrini, E Tirotta, L Benvenuti, ... PLoS One 13 (4), e0195502, 2018 | 63 | 2018 |
| Enteric dysfunctions in experimental Parkinson’s disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats M Fornai, C Pellegrini, L Antonioli, C Segnani, C Ippolito, E Barocelli, ... Journal of Pharmacology and Experimental Therapeutics 356 (2), 434-444, 2016 | 59 | 2016 |
| NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? M Fornai, L Antonioli, R Colucci, C Pellegrini, G Giustarini, L Testai, ... Journal of Pharmacology and Experimental Therapeutics 348 (1), 86-95, 2014 | 56 | 2014 |
| The intestinal barrier in disorders of the central nervous system C Pellegrini, M Fornai, V D'Antongiovanni, L Antonioli, N Bernardini, ... The lancet Gastroenterology & hepatology 8 (1), 66-80, 2023 | 55 | 2023 |
| Preemptive therapy for systemic and pulmonary human cytomegalovirus infection in lung transplant recipients G Gerna, D Lilleri, V Rognoni, M Agozzino, F Meloni, T Oggionni, ... American Journal of Transplantation 9 (5), 1142-1150, 2009 | 54 | 2009 |
| Luteolin prevents cardiometabolic alterations and vascular dysfunction in mice with HFD-induced obesity D Gentile, M Fornai, C Pellegrini, R Colucci, L Benvenuti, E Duranti, ... Frontiers in Pharmacology 9, 1094, 2018 | 52 | 2018 |
